Pre-Treatment Workup — Before Starting Immunotherapy

A set of baseline blood tests and a scan, done before the first dose. In most cases that means a full blood count, kidney and liver function, thyroid function, blood sugar, hepatitis B, hepatitis C and HIV screening, a heart tracing and baseline imaging. Extra tests are added only where your own history calls for them.

The word that matters here is baseline. These tests are not a pass-or-fail exam. They record what normal looks like for you on the day you start, so that any change during treatment can be measured against a real number instead of a guess. Without that starting line, a mildly abnormal thyroid result three months in is almost impossible to interpret — nobody can say whether treatment caused it or whether it was always there.

Most people are never told this. The tests get ordered, a form comes back with ten line items on it, and the worry that follows is entirely avoidable. You are entitled to ask what each test is for and what would happen if it came back abnormal. A good team will answer that in plain language before you agree to anything.

This page is general patient education about the workup itself. It cannot tell you which tests you personally need, or what your results mean. That is decided by your treating medical oncologist, with input from other specialists where your history calls for it.

NCCN, ASCO and ESMO all publish baseline assessment and monitoring recommendations for immune-related side effects. The exact panel varies between centres and between patients — your list may be shorter or longer than this one, and that on its own means nothing about your case.

Because the side effects appear in different places. Chemotherapy mostly affects fast-dividing tissue, so the monitoring follows blood counts. Immunotherapy releases a brake on the immune system, so its side effects are inflammation — and that inflammation can settle in the thyroid, the adrenal glands, the liver, the bowel, the lungs, the skin or the heart.

That is why the baseline panel looks scattered at first glance. It is not scattered. It is one measurement for each organ that immune-related side effects are known to affect, chosen so a later change is measurable rather than arguable.

The second reason is timing. Immune-related side effects do not follow a neat schedule. Some appear within weeks, some after several months, and some appear after treatment has finished. Because they can arrive at any point, the value of a recorded starting point does not fade. A baseline thyroid result taken today is still doing useful work a year from now.

The third reason is that most of these problems are much easier to manage when they are found early. A thyroid result drifting in the wrong direction can be treated before you feel unwell. A liver enzyme rising quietly can be acted on before it becomes a reason to stop treatment altogether. That early window is what the baseline buys you.

One point of scope. This workup is a safety assessment. It is separate from the biomarker testing that helps decide whether immunotherapy is a sensible treatment for your cancer in the first place. The two are often ordered on the same day, which is why they get confused with each other.

If the wait feels long, ask which single result the plan is waiting on. There is almost always one. Knowing what it is turns an open-ended delay into a defined one, and it is a fair question to ask the treating team.

Usually not. Most abnormal baseline results change the monitoring plan rather than cancel treatment. A thyroid result may add an endocrine referral. A positive hepatitis B screen may add antiviral cover and a hepatology opinion. A cardiac finding may add cardiology review and an agreed threshold for pausing. Risk is graded, not switched off.

The situations that need the most caution are the ones where an organ is already under strain, where an autoimmune condition is currently flaring, or where you have had an organ transplant. Even then the answer is usually deferral or a modified plan rather than a flat refusal — and it is a decision made by more than one specialist, not by whoever read the report first.

What you should expect in return is an explanation. If a result changes the plan, ask which result, what it means, and what would have to change for the answer to be different. Being told immunotherapy is risky without being told why is the most common complaint patients bring to a second opinion, and it is not a clinical decision until someone has actually assessed you.

Living with a specific condition changes the detail rather than the principle. If you have rheumatoid arthritis, Immunotherapy With Rheumatoid Arthritis goes through that assessment in depth. If you have Crohn’s disease or ulcerative colitis, Immunotherapy With Inflammatory Bowel Disease covers the bowel-specific questions the workup raises.

Nothing on this page can tell you what your own result means. Baseline values are interpreted in the context of your diagnosis, your other medicines and your symptoms — which is exactly why the interpretation belongs to your treating team and not to a table on a website.

• Every medicine you take, with doses — including steroid tablets, inhalers, insulin, thyroid tablets, herbal or Ayurvedic preparations and anything bought over the counter. Doses matter as much as names.
• Any blood tests from the last few weeks — the printed report, not a remembered result. Recent results are often usable and save you a repeat sample.
• Your scan reports and the images — on a CD or a link, not just the typed report. A baseline comparison needs the actual pictures.
• A short note on other conditions — thyroid, diabetes, heart, liver, kidney, autoimmune disease, tuberculosis, hepatitis, or any transplant. Two lines each is enough.
• The contact details of any other specialist who treats you — so the teams can speak directly rather than relaying messages through you.
• Your questions, written down — particularly what each test is for and which symptoms would mean calling the same day once treatment starts.

• If you live with rheumatoid arthritis, Immunotherapy With Rheumatoid Arthritis explains what the assessment adds for you and how flare risk is weighed.
• If you have Crohn’s disease or ulcerative colitis, Immunotherapy With Inflammatory Bowel Disease covers the bowel-specific baseline and monitoring questions.
• If your thyroid is already treated or under watch, Immunotherapy With Autoimmune Thyroid Disease goes into what the baseline TSH and free T4 are being compared against.
• For how immunotherapy is given, monitored and followed up as day care, see Immunotherapy at CION Cancer Clinics.

General patient-education information only. Nothing here states or implies that immunotherapy is safe or suitable for you, and no test list on this page replaces the one your own oncologist orders. Immunotherapy is administered as day care at CION centres; response-assessment PET-CT is coordinated at partner imaging centres. CION does not provide CAR-T or cell therapy.

Get Your Baseline Workup Explained Properly

A 45-minute consultation covers which tests apply to you, why each one is ordered, what the results would change, and what the monitoring plan looks like once treatment starts.

General patient-education information about the pre-treatment workup, not a substitute for the test list and interpretation your own medical oncologist gives you for your case.